Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers
PR Newswire Asia
*Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1*
OXFORD, England, May 2, 2024 /PRNewswire/..
